​

Century Therapeutics (IPSC) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Century Therapeutics Revenue Highlights

Latest Revenue (Y)

$6.59M

Latest Revenue (Q)

$791.00K

Century Therapeutics Revenue by Period

Century Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$6.59M194.81%
2023-12-31$2.23M-57.01%
2022-12-31$5.20M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Century Therapeutics generated $6.59M in revenue during NA 2024, up 194.81% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Century Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30$791.00K2.59%
2024-06-30$771.00K-9.82%
2024-03-31$855.00K219.03%
2023-12-31$268.00K81.08%
2023-09-30$148.00K49.49%
2023-06-30$99.00K-94.24%
2023-03-31$1.72M230.13%
2022-12-31$521.00K-76.57%
2022-09-30$2.22M59.31%
2022-06-30$1.40M31.95%
2022-03-31$1.06M100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Century Therapeutics generated $791.00K in revenue during Q3 2024, up 2.59% compared to the previous quarter, and up 798.99% compared to the same period a year ago.

Century Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BPMCBlueprint Medicines$508.82M$128.18M
GLUEMonte Rosa Therapeutics$75.62M$4.70M
STOKStoke Therapeutics$36.55M$4.89M
CCCCC4 Therapeutics$20.76M-
GBIOGeneration Bio$19.89M$4.09M
RLAYRelay Therapeutics$10.01M-
IPSCCentury Therapeutics$6.59M$791.00K
KROSKeros Therapeutics$3.55M$37.00K
CGEMCullinan Oncology--
EWTXEdgewise Therapeutics--
KZRKezar Life Sciences--
NKTXNkarta--
MLYSMineralys Therapeutics--
ERASErasca--
PASGPassage Bio--

IPSC Revenue FAQ

What is Century Therapeutics’s yearly revenue?

Century Therapeutics's yearly revenue for 2024 was $6.59M, representing an increase of 194.81% compared to 2023. The company's yearly revenue for 2023 was $2.24M, representing a decrease of -57.01% compared to 2022. IPSC's yearly revenue for 2022 was $5.2M, representing an increase of 100.00% compared to 2021.

What is Century Therapeutics’s quarterly revenue?

Century Therapeutics's quarterly revenue for Q3 2024 was $791K, a 2.59% increase from the previous quarter (Q2 2024), and a 434.46% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $771K, a -9.82% decrease from the previous quarter (Q1 2024), and a 678.79% increase year-over-year (Q2 2023). IPSC's quarterly revenue for Q1 2024 was $855K, a 219.03% increase from the previous quarter (Q4 2023), and a -50.29% decrease year-over-year (Q1 2023).

What is Century Therapeutics’s revenue growth rate?

Century Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 26.74%, and for the last 5 years (2020-2024) was 0%.